Clinical trial Recruiting at 1 site Observational Ages 2 to 16

Screening siblings of children with autism for neurodevelopmental disorders

Official title: Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers

Run by University Hospital, Montpellier · NCT05512637 · Data updated 2026-11-12

This study is testing a new way to check if siblings of children with autism have any neurodevelopmental disorders to better understand their needs.

More Autism Spectrum Disorder trials

Quick facts

Study typeObservational
Ages2 Years to 16 Years
SexAll
Enrollment384 (estimated)
SponsorUniversity Hospital, Montpellier
Academic / other
Locations1 site (Montpellier)
StatusRecruiting
StartedNovember 28, 2023
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedMarch 30, 2025
Trial IDNCT05512637 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are siblings aged 2 to 16 years of children diagnosed with autism, living in the Occitanie region of France.

Probably not a fit

Patients who may not benefit from this study include adopted siblings or those who do not speak French.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on screening siblings of children diagnosed with Autism Spectrum Disorder (ASD) for neurodevelopmental disorders (NDD). It employs a multi-stage screening process to estimate the prevalence of NDD among these siblings and evaluates the feasibility and acceptability of a standardized screening procedure. The study aims to improve understanding of the developmental needs of these siblings, which are often overlooked in routine practice.

Why it matters

Potential benefit: If successful, this study could lead to earlier identification and intervention for neurodevelopmental disorders in siblings of children with autism.

How similar studies have gone: Other studies have indicated the importance of screening siblings of children with autism, suggesting that this approach could yield valuable insights and improvements in developmental surveillance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Step 1: Brothers or sisters (including stepsisters and brothers); aged between 2 and 16 years; living in Occitanie; informed and express consent of parents ; affiliated to social security.
* Step 2: step 1 positive screening or parental concerns for child's development ; parental signed informed consent.

Exclusion Criteria:

* Parents (or child) refusal to participate; adopted brother or sister. Do not speak French

Where it's running

  • Chu Montpellier
    Montpellier, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.